Red Blood Cell Production Using Constitutively Active SCF
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing red blood cells in vitro are limited by the need for donor cells, genetic heterogeneity, and the instability and low growth rate of cell lines, making large-scale production challenging.
Innovation Solution
A method involving the differentiation of genetically modified pluripotent stem cells with a constitutively active SCF receptor in cytokine-free media, using erythropoietin, dexamethasone, and IBMX, to produce enucleated red blood cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If immortalized cell lines are used for red blood cell production, then unlimited cell production is achieved, but the cell lines exhibit karyotypic instability and low growth rate
Solution Approach 1:
The invention changes the genetic parameter of the stem cells by introducing a constitutively active cytokine receptor (such as a mutated SCF receptor with D816V substitution) that signals continuously without requiring external cytokines. This parameter change enables immortalized cell lines to maintain karyotypic stability while achieving unlimited proliferation and differentiation capacity into red blood cells
2Manufacturing precision
If primary hematopoietic stem and progenitor cells are used, then differentiation into red blood cells is achieved, but the need to collect cells from volunteers remains and genetic heterogeneity exists
Solution Approach 1:
The invention creates a self-sustaining cell line that copies itself through continuous proliferation without requiring repeated collection from donor volunteers. The constitutively active receptor enables the cell line to generate unlimited copies of genetically homogeneous cells that can all differentiate into red blood cells, eliminating the need for ongoing donor collections
Solution Approach 2:
The invented cell line serves multiple functions: it can self-renew indefinitely, differentiate into red blood cells, and provide a genetically homogeneous source for unlimited production. This multi-functionality replaces the need for separate steps of donor collection, cell expansion, and differentiation that are required when using primary cells
3Quantity of substance
If in vitro production methods are used, then genetically homogeneous cells can be produced, but large-scale production remains challenging due to cell line instability
Solution Approach 1:
The invention changes the signaling parameter of the cell line by implementing a constitutively active cytokine receptor that provides continuous internal signals for proliferation and differentiation. This parameter change enables the cell line to maintain stability and differentiation capacity at large scales without the karyotypic instability that plagues existing immortalized lines
Data Source
AI summary
This disclosure is based, at least in part, on the unexpected discovery that genetically modified pluripotent stem cells having a constitutively active stem cell factor (SCF) can differentiate into enucleated red blood cells, self-renew, and expand in culture media for an extended period of time. Accordingly, the disclosed methods enable large-scale production of red blood cells with significantly reduced overall cost as compared to the existing methods.